SyncThink, a Palo Alto-based startup applying VR and eye-tracking to assess ability to focus as an indicator of concussion damage, announced a new clinical advisory board. The new members include Dr. Jeffrey Kutcher, Dr. Kristen Steenerson, Dr. Leonore Herget, Dr. Marie Boo and Dr. Gordon Matheson.
These new members come from a variety of backgrounds including neurology, sport sciences and even the US Ski and Snowboard team. The board will be focused on providing expert feedback and gathering user feedback.
“We are thrilled to be working with these experts who bring decades of clinical research and evidence-based practice to the SyncThink team that will help us further the mission of developing a robust, multi-functional platform that services the needs of many healthcare professionals,” Laura Yecies, CEO of SyncThink, said in a statement.
This morning venture investing fund Flare Capital tapped Parth Desai to join as its new senior associate.
Desai comes to the firm after working with New York Presbyterian’s investment team. Previously he worked for Deloitte Consulting and the Massachusetts House of Representatives. He comes to the role with a Masters of Arts in Clinical Medicine and a Masters of Public Health in Health Management and Policy from Boston University.
In mid-March CherryCircle, a software company focused on accelerating pharmaceutical manufacturing process development, announced that Emma Cartmell will be joining its board.
Cartmell is an angel investor focusing on affordable high impact products. She also serves on several boards including HIMSS North America, Austin Healthcare council and Morgan Stanley Equity Expansion fund.
“CherryCircle’s QbDVision solution is the type of innovation the pharmaceutical industry needs,” Cartmell said in a statement. “I believe in their vision to reduce the amount of time and expense it takes to bring drugs and medical devices to market and this team has the experience to make it happen.”